封面
市場調查報告書
商品編碼
1530007

心臟定位設備市場規模、佔有率、趨勢分析報告:按類型、按適應症、按最終用途、按地區、細分市場預測,2024-2030 年

Cardiac Mapping Devices Market Size, Share & Trends Analysis Report, By Type, By Indication, By End Use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

心臟定位設備市場成長與趨勢:

根據Grand View Research, Inc的最新報告,預計2030年全球心臟定位設備市場規模將達36.9億美元,2024年至2030年複合年成長率為9.1%。

促進市場擴張的主要因素包括心律不整病例和心血管手術患者數量的增加、老年人口的增加、心臟定位系統的技術進步以及政府的支持措施。根據心律協會 2023 年 8 月發表的一篇論文,心房顫動 (AFib) 是最常見的心律不整類型,影響全球約 4000 萬人,其中美國有 600 萬人。

40 歲以上的成年人中,大約四分之一有心房顫動的風險,但許多人不知道其症狀、可用的治療方法以及早期療育以防止進展的重要性。心臟定位系統的進步也將推動市場成長。例如,2024 年 6 月,將引入新的映射技術,例如在心外膜上繪製心臟動脈和靜脈的多電極籃和導管,使得真空治療期間的3D活化序列成為可能。電腦化非接觸式測繪使用數學演算法重建電圖並創建3D電位圖,而無需直接接觸心內膜。

心臟電生理學遠端監測和感染預防方面的進步使得在臨床環境之外持續監測患者的心率成為可能,從而可以快速調整治療並降低侵入性手術造成的感染風險。此外,主要企業的多項策略措施正在推動市場成長。例如,強生公司的 BioSense Webster 於 2024 年 7 月推出了 Optrell,這是一種採用 TrueRef 技術的標測導管。 Optrell 由加州歐文市的 Biosense Webster 設計,是一種與 Carto 3 系統整合的高密度診斷導管。小電極放置在固定陣列中,以提供複雜心律不整的精確電生理學定位。

心臟定位設備市場報告亮點

  • 由於技術進步、主要企業的策略性舉措以及心血管手術量的增加,接觸式心臟定位系統領域在 2023 年佔據最大佔有率,超過 57.07%。
  • 由於心律不整病例增加及老年人口增加,2023年心房顫動細分市場佔比最大,超過45.87%。
  • 2023年,醫院板塊佔比最大,為69.38%。醫院在採用和評估先進心臟定位設備等新技術方面發揮著重要作用。這些設備使醫院能夠為心律不整患者提供最先進的治療,確保更好的結果並推動電生理學領域的發展。
  • 由於包括心律不整在內的心血管疾病(CVD)患者數量不斷增加,2023年北美佔全球市場的41.39%。產品發布、監管核准和先進的醫療基礎設施。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章全球心臟定位設備市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 心臟定位設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章心臟定位設備市場:類型估計與趨勢分析

  • 心臟定位設備市場:模式儀表板
  • 心臟定位設備市場:類型變化分析
  • 2018-2030 年心臟定位設備市場規模、預測與趨勢分析(按類型)
  • 關於心臟定位系統的詢問
  • 非接觸式心臟定位系統

第5章心臟定位設備市場:適應症估計與趨勢分析

  • 心臟定位設備市場:自適應儀表板
  • 心臟定位設備市場:自適應變異分析
  • 2018-2030 年心臟定位設備市場規模、預測與趨勢分析(依適應症)
  • 心房顫動
  • 心房撲動
  • 其他

第6章心臟定位設備市場:最終用途估計與趨勢分析

  • 心臟定位設備市場:最終用途儀表板
  • 心臟定位設備市場:最終用途變化分析
  • 2018-2030 年心臟定位設備市場規模、預測與趨勢分析(依最終用途)
  • 醫院
  • 診斷中心
  • 其他

第7章心臟定位設備市場:按國家、類型、最終用途和最終用途進行的區域估計和趨勢分析

  • 全球心臟定位設備市場:區域儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 主要製造商的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Abbott
    • Medtronic
    • BIOTRONIK
    • Acutus Medical
    • APN Health, LLC
    • Johnson &Johnson
    • Biosig Technologies, Inc.
    • Boston Scientific Corporation
    • Kardium, Inc.
    • Koninklijke Philips NV
    • Microport Scientific Corporation
Product Code: GVR-4-68040-381-1

Cardiac Mapping Devices Market Growth & Trends:

The global cardiac mapping devices market size is expected to reach USD 3.69 billion by 2030, registering a CAGR of 9.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market expansion include the rising arrhythmia cases & number of cardiac surgery patients, growing geriatric population, technological advancements in cardiac mapping systems, and supportive government initiatives. According to the Heart Rhythm Society article published in August 2023, Atrial fibrillation (AFib), the most common type of cardiac arrhythmia, affects nearly 40 million people worldwide, including 6 million in the U.S. Its widespread prevalence underscores the need for advanced diagnostic and treatment options.

Approximately 1 in 4 adults over 40 are at risk of developing AFib, yet many are unaware of its symptoms, available treatments, and the importance of early intervention to prevent progression. Advancements in cardiac mapping systems also drive market growth. For instance, in June 2024, new mapping techniques, such as multielectrode baskets and catheters mapping across cardiac arteries and veins on the epicardium, enabled three-dimensional activation sequence definition during vacuum therapy. Computerized non-contact mapping uses mathematical algorithms to reconstruct electrograms and generate three-dimensional isopotential maps without direct heart endocardium contact.

Advances in remote monitoring and infection prevention in cardiac electrophysiology support continuous patient heart rhythm monitoring outside clinical settings, allowing prompt treatment adjustments and reducing invasive procedure infection risks. Moreover, several strategic initiatives by key players fuel the market's growth. For instance, in July 2024, Johnson & Johnson's Biosense Webster launched the Optrell mapping catheter, incorporating TrueRef technology. Designed in Irvine, California, by Biosense Webster, Optrell is a high-density diagnostic catheter that integrates with the Carto 3 system. It utilizes small electrodes in a fixed array configuration to provide accurate electrophysiological mapping for complex cardiac arrhythmias.

Cardiac Mapping Devices Market Report Highlights:

  • The contact cardiac mapping systems segment held the largest share of over 57.07%, in 2023 due to technological advancements, strategic initiatives by key players, and a rising volume of cardiac procedures
  • The atrial fibrillation segment held the largest share of over 45.87% in 2023 due to increased cases of arrhythmia and high geriatric population
  • The hospitals segment held the largest share of 69.38% in 2023. Hospitals play a vital role in adopting and assessing new technologies, such as advanced cardiac mapping devices. These devices enable hospitals to deliver state-of-the-art care for patients with cardiac arrhythmias, ensuring better outcomes and advancing the field of electrophysiology
  • North America dominated the global market with a share of 41.39% in 2023 owing to the increased cases of cardiovascular diseases (CVDs), including arrhythmias. Product launches, regulatory approvals, and advanced healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Indication
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecast timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Segment
    • 2.2.2. Indication Segment
    • 2.2.3. End-use Segment
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Cardiac Mapping Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing number of cardiac surgery patients
      • 3.2.1.2. Rising arrhythmia cases
      • 3.2.1.3. Technological advancements in mapping systems
      • 3.2.1.4. Growing number of cardiovascular diseases (CVD)
      • 3.2.1.5. Rising geriatric population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of cardiac mapping systems
      • 3.2.2.2. Lack of adequate infrastructure
  • 3.3. Cardiac Mapping Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Cardiac Mapping Devices Market: Type Estimates & Trend Analysis

  • 4.1. Cardiac Mapping Devices Market: Type Dashboard
  • 4.2. Cardiac Mapping Devices Market: Type Movement Analysis
  • 4.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Contact cardiac mapping systems
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Non-contact cardiac mapping systems
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Cardiac Mapping Devices Market: Indication Estimates & Trend Analysis

  • 5.1. Cardiac Mapping Devices Market: Indication Dashboard
  • 5.2. Cardiac Mapping Devices Market: Indication Movement Analysis
  • 5.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 5.4. Atrial Fibrillation
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Atrial Flutter
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Cardiac Mapping Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Cardiac Mapping Devices Market: End Use Dashboard
  • 6.2. Cardiac Mapping Devices Market: End Use Movement Analysis
  • 6.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Centers
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Cardiac Mapping Devices Market: Regional Estimates & Trend Analysis by Country, Type, End-use, & End Use

  • 7.1. Global Cardiac Mapping Devices Market: Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework/ reimbursement structure
      • 7.3.4.3. Competitive scenario
      • 7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. South Africa
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Abbott
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Medtronic
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. BIOTRONIK
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Acutus Medical
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. APN Health, LLC
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Johnson & Johnson
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Biosig Technologies, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Boston Scientific Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Kardium, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Koninklijke Philips N.V
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Microport Scientific Corporation
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 5 Global cardiac mapping devices market, by end-use, 2018 - 2030
  • Table 6 Global cardiac mapping devices market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 9 North America cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 10 North America cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 12 U.S. cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 13 U.S. cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Canada cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 16 Canada cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Mexico cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 18 Mexico cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 19 Mexico cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 22 Europe cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 23 Europe cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 25 UK cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 26 UK cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Germany cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 28 Germany cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Germany cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 France cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 31 France cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 32 France cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Italy cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 34 Italy cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 35 Italy cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Spain cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 37 Spain cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 38 Spain cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Denmark cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 40 Denmark cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 41 Denmark cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Sweden cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 43 Sweden cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 44 Sweden cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Norway cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 46 Norway cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 47 Norway cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific cardiac mapping devices market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Japan cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 53 Japan cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 54 Japan cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 China cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 56 China cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 57 China cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 India cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 59 India cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 60 India cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Australia cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
  • Table 62 Australia cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 63 Australia cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 64 Australia cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Thailand cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 68 Thailand cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 South Korea cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 70 South Korea cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 71 South Korea cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Latin America cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
  • Table 73 Latin America cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 74 Latin America cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Latin America cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Brazil cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 77 Brazil cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 78 Brazil cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Argentina cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 80 Argentina cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 81 Argentina cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 MEA cardiac mapping devices market, by country, 2018 - 2030 (USD Million)
  • Table 83 MEA cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 84 MEA cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 85 MEA cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 South Africa cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 87 South Africa cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 88 South Africa cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 UAE cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 93 UAE cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 94 UAE cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Kuwait cardiac mapping devices market, by type, 2018 - 2030 (USD Million)
  • Table 96 Kuwait cardiac mapping devices market, by indication, 2018 - 2030 (USD Million)
  • Table 97 Kuwait cardiac mapping devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 98 Participant's overview
  • Table 99 Financial performance
  • Table 100 Key companies undergoing expansions
  • Table 101 Key companies undergoing acquisitions
  • Table 102 Key companies undergoing collaborations
  • Table 103 Key companies launching new types/services
  • Table 104 Key companies undergoing partnerships
  • Table 105 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Cardiac mapping devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Cardiac mapping devices market revenues, 2023, (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Cardiac mapping devices market type outlook:
  • Fig. 14 Cardiac mapping devices market: type movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global contact cardiac mapping systems market, 2018 - 2030 (USD Million)
  • Fig. 17 Global non-contact cardiac mapping systems market, 2018 - 2030 (USD Million)
  • Fig. 18 Cardiac mapping devices market indication outlook:
  • Fig. 19 Cardiac mapping devices market: indication movement analysis
  • Fig. 20 Global atrial fibrillation market, 2018 - 2030 (USD Million)
  • Fig. 21 Global atrial flutter market, 2018 - 2030 (USD Million)
  • Fig. 22 Global others market, 2018 - 2030 (USD Million)
  • Fig. 23 Cardiac mapping devices market end-use outlook:
  • Fig. 24 Cardiac mapping devices market: end-use movement analysis
  • Fig. 25 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 26 Global diagnostic centers market, 2018 - 2030 (USD Million)
  • Fig. 27 Global others market, 2018 - 2030 (USD Million)
  • Fig. 28 Regional market place: Key takeaways
  • Fig. 29 North America cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 34 Germany cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 35 UK cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 36 France cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Italy cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Spain cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 40 Japan cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 41 China cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 42 India cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Australia cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 46 MEA cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 47 South Africa cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Saudi Arabia cardiac mapping devices market, 2018 - 2030 (USD Million)
  • Fig. 49 Market Participant Categorization
  • Fig. 50 Strategy mapping